Lotrimin Ultra

Manufacturer
Bayer HealthCare LLC.
Effective date
2017-02-06
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 01:20:02

Label at a glance#

ProductLotrimin Ultra Antifungal
Active ingredientBUTENAFINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

cures most athlete's foot between the toes. Effectiveness on the bottom or sides of foot is unknown. cures most jock itch and ringworm relieves itching, burning, cracking, and scaling which accompany these conditions

Dosage and administration

adults and children 12 years and older: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot between the toes : apply to affected skin between and around the toes twice a day for 1 week (morning and night), or once a day for 4 weeks, or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes an...

Storage and handling

do not use if seal on tube is broken or not visible store between 20° to 25°C (68° to 77°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Butenafine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • cures most athlete's foot between the toes. Effectiveness on the bottom or sides of foot is unknown.
  • cures most jock itch and ringworm
  • relieves itching, burning, cracking, and scaling which accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on nails or scalp
  • in or near the mouth or the eyes
  • for vaginal yeast infections

OTC - WHEN USING SECTION

When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if too much irritation occurs or irritation gets worse

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and older:
    • use the tip of the cap to break the seal and open the tube
    • wash the affected skin with soap and water and dry completely before applying
    • for athlete's foot between the toes: apply to affected skin between and around the toes twice a day for 1 week (morning and night), or once a day for 4 weeks, or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
    • for jock itch and ringworm: apply once a day to affected skin for 2 weeks or as directed by a doctor
    • wash hands after each use
  • children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • do not use if seal on tube is broken or not visible
  • store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetyl alcohol, diethanolamine, glycerin, glyceryl monostearate SE, polyoxyethylene (23) cetyl ether, propylene glycol dicaprylate, purified water, sodium benzoate, stearic acid, white petrolatum

Questions?

OTC - QUESTIONS SECTION

866-360-3226

SPL UNCLASSIFIED SECTION

Distributed by MSD Consumer Care, Inc., PO Box 377, Memphis, TN 38151 USA, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 30g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOTRIMIN ULTRA®

butenafine hydrochloride cream 1%
ANTIFUNGAL

NET WT 30g (1.1 OZ)

PRINCIPAL DISPLAY PANEL - 30g Tube Carton
PRINCIPAL DISPLAY PANEL - 30g Tube Carton

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11523-7154-3GM - Gram11523-7154bc0b2d8d-4da3-43d7-a781-84d6b366d3ab12013-09-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Butenafine HydrochlorideACTIVE INGREDIENTR8XA2029ZI2
ButenafineACTIVE MOIETY91Y494NL0X2
benzyl alcoholINACTIVE INGREDIENTLKG8494WBH2
ceteth-23INACTIVE INGREDIENT495CTZ441V2
cetyl alcoholINACTIVE INGREDIENT936JST6JCN2
diethanolamineINACTIVE INGREDIENTAZE05TDV2V2
glycerinINACTIVE INGREDIENTPDC6A3C0OX2
petrolatumINACTIVE INGREDIENT4T6H12BN9U2
propylene glycol dicaprylateINACTIVE INGREDIENT581437HWX22
sodium benzoateINACTIVE INGREDIENTOJ245FE5EU2
stearic acidINACTIVE INGREDIENT4ELV7Z65AP2
waterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11523-715411523-7154-1, 11523-7154-2, 11523-7154-3, 11523-7154-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 228 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
glycerinGLYCERINPDC6A3C0OXPASTE, DENTIFRICE / DENTAL18 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
petrolatumPETROLATUM4T6H12BN9ULOTION / TOPICAL25 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUPOWDER, FOR SOLUTION / ORAL98 mgExact identifier — unii candidate
35 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / SOFT TISSUE40 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNSUSPENSION / AURICULAR (OTIC)1 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
petrolatumPETROLATUM4T6H12BN9USOAP / TOPICAL0.85 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNTABLET, ORALLY DISINTEGRATING / ORAL9 mgExact identifier — unii candidate
20 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRASYNOVIAL18 mgExact identifier — unii candidate
50 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUPASTE, DENTIFRICE / DENTAL0.5 %w/wExact identifier — unii candidate
35 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHTABLET / ORAL1.06 mgExact identifier — unii candidate
50 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION, CONCENTRATE / ORAL200 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHLOTION / TOPICAL4000 mgExact identifier — unii candidate
50 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSOLUTION / INTRAVENOUS242 mgExact identifier — unii candidate
50 equally ranked IID candidates
stearic acidSTEARIC ACID4ELV7Z65APCREAM / VAGINAL1088 mgExact identifier — unii candidate
26 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS18 mgExact identifier — unii candidate
50 equally ranked IID candidates
stearic acidSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii candidate
26 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHGEL / VAGINAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS144 mgExact identifier — unii candidate
50 equally ranked IID candidates
diethanolamineDIETHANOLAMINEAZE05TDV2VCREAM / TOPICAL0.3 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSPRAY / NASAL5 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNAEROSOL, FOAM / TOPICAL82 mgExact identifier — unii candidate
20 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSOLUTION / TOPICAL2 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
stearic acidSTEARIC ACID4ELV7Z65APTABLET, ORALLY DISINTEGRATING / ORAL10 mgExact identifier — unii candidate
26 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNAEROSOL, FOAM / RECTAL17 mgExact identifier — unii candidate
20 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXPASTE / ORAL3822 mgExact identifier — unii candidate
75 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNCAPSULE, DELAYED RELEASE / ORAL59 mgExact identifier — unii candidate
20 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii candidate
20 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXINJECTION, EMULSION / INTRAVENOUS24100 mgExact identifier — unii candidate
75 equally ranked IID candidates
petrolatumPETROLATUM4T6H12BN9UOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
18 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHCAPSULE, EXTENDED RELEASE / ORAL1.23 mgExact identifier — unii candidate
50 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii candidate
75 equally ranked IID candidates
stearic acidSTEARIC ACID4ELV7Z65APIMPLANT / SUBCUTANEOUS1.04 mgExact identifier — unii candidate
26 equally ranked IID candidates
petrolatumPETROLATUM4T6H12BN9UCAPSULE / VAGINALNAExact identifier — unii candidate
18 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXDROPS / ORAL300 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
petrolatumPETROLATUM4T6H12BN9UAEROSOL, FOAM / TOPICAL7.9 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUINJECTION / INTRAVENOUS864 mgExact identifier — unii candidate
35 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUGRANULE / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSUPPOSITORY / VAGINAL227.9 mgExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
stearic acidSTEARIC ACID4ELV7Z65APOINTMENT / TOPICAL15 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
petrolatumPETROLATUM4T6H12BN9UOINTMENT / VAGINAL4084 mgExact identifier — unii candidate
18 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXTABLET / ORAL42 mgExact identifier — unii candidate
75 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUFILM / BUCCAL1 mgExact identifier — unii candidate
35 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXCREAM / VAGINAL60 mgExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXTABLET, CHEWABLE / ORAL12 mgExact identifier — unii candidate
75 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXEMULSION / OPHTHALMIC3 mgExact identifier — unii candidate
75 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUSYSTEM / TOPICAL2 mgExact identifier — unii candidate
35 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUINJECTION, EMULSION / INTRAVENOUS0.1 %w/vExact identifier — unii candidate
35 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSYSTEM / TOPICAL18144 mgExact identifier — unii candidate
75 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHCREAM / TOPICAL160 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetyl alcoholCETYL ALCOHOL936JST6JCNCREAM / VAGINAL200 mgExact identifier — unii candidate
20 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCUTANEOUS90 mgExact identifier — unii candidate
50 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUSPONGE / TOPICALNAExact identifier — unii candidate
35 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021307-001LOTRIMIN ULTRABUTENAFINE HYDROCHLORIDE1%CREAM / TOPICALRLD, RS2001-12-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07c2088c7a36db…
2026-09-14 22:38:342026-08N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-0784e616aacf4f…
2026-08-18 06:07:402026-07N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-0731067a03dcf5…
2025-08-23 18:47 UTC2025-08N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-076a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-0703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-072680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-075bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-0779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-071e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-078072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-075c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-075d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-074b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-0774a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-0787673890dc5c…
2021-03-12 10:30 UTC2021-03N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-075aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-078869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-073f01610625f2…
2019-09-15 20:21 UTC2019-09N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07b00525d2431f…
2019-07-19 19:46 UTC2019-07N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-076a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-071c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-079b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-073f0d92c62455…
2023-05-13 08:27 UTC2023-05N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-07053a50430f4f…
2023-01-26 05:58 UTC2023-01N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-073bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021307-001LOTRIMIN ULTRA1%CREAM / TOPICALRLD, RS2001-12-073a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
198668a2-3429-2d88-e063-6294a90a75ad0eadac26-4619-4227-9dda-28e739d77a872024-05-28WarningsExact identifier
spl set id: 0eadac26-4619-4227-9dda-28e739d77a87

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.